Search

Search Constraints

You searched for: Author/Creator Kim Tae-Hwan author non-byline.

Search Results

1. Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y). Issue 8 (6th May 2021)

2. Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial. Issue 8 (7th April 2021)